Form 4 for OGN Organon & Co.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001209191-23-014878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-02-28 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | M - OptEx | — | +4,616 | 6,912 | +201% | — |
| D | 2023-03-02 | 2023-02-28 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | F - Tax | $25.09 | -1,431 | 5,481 | -21% | -$35.9K |
| D | 2023-03-02 | 2023-02-28 | OGN | Weaver Kirke | Gen. Counsel, Corp. Secy | M - OptEx | $0.00 | -4,616 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | M | A | 4,616 | — | 6,912 | D | — | — | (F1) Each Restricted Stock Unit converts into one share of Organon & Co. common stock. |
| 2 | Common | Common Stock | 2023-02-28 | F | D | 1,431 | $25.09 | 5,481 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 4,616 | $0.00 | 0 | D | — · 2022-12-31 to 2022-12-31 | 4,616 Common Stock | (F2) As originally reported on the Form 3, dated January 10, 2023, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023. (F1) Each Restricted Stock Unit converts into one share of Organon & Co. common stock. |